ElevateBio Executive and Leadership Team

Gerard Brophy, the Chief Executive Officer at ElevateBio, directs the overarching strategy and operational framework for the company's portfolio of cell and gene therapy ventures. Brophy guides the establishment and expansion of new therapeutic companies, fostering collaborations with leading scientific innovators. Overseeing the integration of diverse scientific platforms, Gerard Brophy ensures alignment with ElevateBio's mission to develop and deliver transformative treatments. This leadership role involves shaping the company's strategic direction, securing critical partnerships, and driving the commercialization of groundbreaking cell and gene therapies. Brophy's focus remains on building a robust ecosystem that accelerates the translation of scientific discoveries into patient-ready solutions, solidifying ElevateBio's position at the forefront of regenerative medicine.

Bhakti Bhargava, the Chief Financial Officer at ElevateBio, manages all financial operations and strategic fiscal planning for the company and its portfolio entities. Bhargava oversees capital allocation, investment strategies, and financial reporting, ensuring robust fiscal health across the organization. This executive drives financial modeling for new venture formation and supports fundraising initiatives critical to ElevateBio's growth. By optimizing financial structures, Bhakti Bhargava enables the company to effectively scale its operations and invest in cutting-edge cell and gene therapy development. Bhargava's expertise is vital in navigating the complex financial landscape of the biotechnology sector, supporting the long-term sustainability and expansion of ElevateBio's innovative business model.

Kareem Reda, the Chief Operating Officer at ElevateBio, oversees the operational execution and scaling of the company's diverse portfolio of cell and gene therapy businesses. Reda directs the integration of operational best practices across all ventures, ensuring efficient development and manufacturing processes. This leadership position involves optimizing supply chains, managing operational infrastructure, and enhancing cross-functional collaboration to accelerate therapeutic delivery. By streamlining operations, Kareem Reda supports the seamless transition of scientific breakthroughs from research to clinical application. Reda's strategic oversight is crucial for maintaining high standards of quality and compliance, enabling ElevateBio to effectively bring life-changing therapies to market.

Michael Paglia, the Chief Technology Officer, Elevatebio Basecamp at ElevateBio, leads the technological innovation and infrastructure development for the company's core development and manufacturing hub. Paglia directs the implementation of advanced technologies and scientific platforms essential for cell and gene therapy production. This role involves architecting scalable technological solutions that support the rapid advancement of novel therapeutic programs. By driving technological excellence, Michael Paglia ensures that Elevatebio Basecamp remains at the cutting edge of biomanufacturing and process development. Paglia's expertise is fundamental to translating complex scientific requirements into robust, efficient, and compliant technological systems, accelerating the delivery of next-generation therapies.